Atrial fibrillation
KEYWORDS: fibrillation, atrial, atrial fibrillation, adults, quality, adults atrial, anticoagulation, data, statement, stroke, nice, source, local, risk, quality statement

edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation. Minor changes since publication December 2025: Links have been updated throughout to NICE's HealthTech guidance 353, which replaces NICE's diagnostics guidance on self-monitoring coagulation status using point-of-care coagulometers. June 2021: Further information was added to bleeding risk score in the definitions section of statement 1. April 2021: Source guideline recommendation numbers were updated throughout and definitions for statements 1 and 2 were amended in line with the updated NICE guideline on atrial fibrillation. About this quality standard NICE quality standards describe high-priority areas for quality improvement in a defined care or service area. Each standard consists of a prioritised set of specific, concise and measurable statements. NICE quality standards draw on existing NICE or NICE-accredited guidance that provides an underpinning, comprehensive set of recommendations, and are designed to support the measurement of improvement. Expected levels of achievement for quality measures are not specified. Quality standards are intended to drive up the quality of care, and so achievement levels of 100% should be aspired to (or 0% if the quality statement states that something should not be done). However, this may not always be appropriate in practice. Taking
